期刊文献+

C57BL/6J小鼠EAE模型的建立及巨噬细胞移动抑制因子的表达 被引量:1

Mouse model of experimental antoimmune encephalomyelitisin C57BL/6J and expression of macrophage migration inhibitory factor
下载PDF
导出
摘要 目的:通过观察巨噬细胞移动抑制因子(macrophage migration inhibitory factor,MIF)在慢性实验性变态反应性脑脊髓炎(experimental autoimmune encephalomyelitis,EAE)小鼠脑和脊髓中的动态表达变化,探讨MIF与EAE发病的关系。方法:72只无特定病原体的6-8周健康雌性C57BL/6J小鼠随机分为EAE组、空白组和佐剂组。用mMOG35-55和完全弗氏佐剂(complete Freund’s adjuvant,CFA)免疫小鼠制成慢性EAE动物模型,免疫组织化学技术检测不同组别小鼠脑和脊髓中MIF的表达变化。结果:EAE组小鼠在疾病各个时期,中枢神经系统(CNS)中均可见MIF表达升高,各个时期MIF表达与空白组和佐剂组相比均有统计学意义(P〈0.05);在EAE组,MIF在疾病发病高峰期表达最高,与其他时间点相比差异有统计学意义(P〈0.05)。结论:MIF在EAE小鼠发病过程中有明显表达,可能与EAE的发病和恶化相关。 Objective To detect the expression of macrophage migration inhibitory factor (MIF) in the brain and spinal cord of chronic non-remitting model of experimental autoimmune encephalomyelitis (EAE) mouse, and to discuss their effect on EAE/MS. Methods Seventy-two female SPF C57BL/6J mice, aged 6 -8 weeks, were randomly divided into an EAE group, a blank group, and an adjuvant group. The mice were immuned by mMOG35.55 and CFA. Immunohistochemic technique was used to detect the expression of MIF in the brain and spinal cord. Results In the EAE group, we observed up-regulation of MIF of central nervous system (CNS) at onset, peak and chronic phase. During each phase, the difference of MIF between the EAE group and each of the other 2 groups was significant ( P 〈 0.05 ). In the EAE group, the expression of MIF was the highest at the peak, which was different from other periods ( P 〈 0.05 ). Conclusion MIF significanty expressed during the procedure of EAE disease, and may be related with the onset and exacerbation of EAE.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2008年第10期931-936,共6页 Journal of Central South University :Medical Science
基金 湖南省科技厅资助项目(2007SK3032)~~
关键词 实验性变态反应性脑脊髓炎 巨噬细胞移动抑制因子 免疫组织化学 experimental autoimmune encephalomyelitis factor immunohistochemistry macrophage migration inhibitory
  • 相关文献

参考文献11

  • 1Kuerten S, Kostova-Bales D A, Frenzel L P, et al. MP4- and MOG: 35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum [ J ]. J Neuroimmunol, 2007, 189(1-2) : 31-40.
  • 2David J. Delayed-type-hypersensitivity in vitro:its mediation by cell- free substances formed by lymphoid cell-antigen interaction[J]. Proc Natl Acad Sci USA, 1966,56(1):72- 77.
  • 3Bynoe M S, Bonorino P, Viret C. Control of experimental autoimmune encephalomyelitis by CD4 ^+ suppressor T cells: Peripheral versus in situ immunoregulation [ J ] . J Neuroimmunol, 2007,191 (1-2) : 61-69.
  • 4Bacher M, Metz C N, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T- cell activation [ J ]. Proc Natl Acad Sci USA, 1996,93 (15) :7849-7854.
  • 5Collette Y, Razabahaona D, Ghiotto M, et al. CD28 can promote T cell survival through a phosphatidylinositol 3-ki- naseindependent mechanism [ J ] . Eur J Immunol, 1997 , 27(12) :3283-3289.
  • 6Radvanyi L G, Shi Y, Vaziri H, et al. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response[J]. J Immunol,1996,156(5) :1788-1798.
  • 7Walker L S, Mcleod J D, Boulougouris G, et al. Downregulation of CD28 via Fas ( CD95 ) : influence of CD28 on T-cell apoptosis [ J]. Immunology, 1998,94 ( 1 ) :41- 47.
  • 8Stichel C C, Luebbert H. Inflammatory processes in the aging mouse brain: Participation of dendritic cells and T-cells [J]. Neurobiol Aging, 2007, 28(10) : 1507-1521.
  • 9Wang B, Huang X, Wolters P J,et al. Cutting edge: Deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses [ J ]. J hnmunol ,2006, 177 (9) :5779-5784.
  • 10Larson D F, Horak K. Macrophage migration inhibitory factor: controller of systemic inflammation [ J ]. Crit Care, 2006,10(2) :138.

同被引文献19

  • 1Petrone AB, Simpkins JW, Barr TL. 17[3-Estradiol and inflam- mation: implications for ischemic stroke [J]. AgingDis,2014,5 (5):340-345.
  • 2Salem ML. Estrogen, A double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regula- tion of TH1/TH2 cytokine production [J]. Curr Drug Targets- Inflam Allergy, 2004, 3( 1 ):97-104.
  • 3Jasnow AM, Schulkin J, Pfaff DW. Estrogen facilitates fear conditioning and increases corticotropin-releasing hormone Mr- na expression in the central amygdala in female mice[J]. Horm Behav, 2006,49(2): 197-205.
  • 4Ishimaru N, Saegusa K, Yanagi K. et ol. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjigren's syn- drome through fas-mediated apoptosis [J]. Am J Pothol, 1999 , 155(1):173-181.
  • 5Bodhankar S, Galipeau D, Vandenbark AA. et al. PD-1 Inter- actionwith PD-L1 but not PD-L2 on B-cells mediates protective effects of estrogen against EAE[J]. Clin Cell lmmunol, 2013,4 (3): 143.
  • 6Bodhankar S, Wang C, Vandenbark AA, et ol. Estrogen-in- duced protection against experimental encephalomyelitis is abm-gated in the absence of B cells [ J]. Eur J lmmunol, 2011, 41(4): 1165-1175.
  • 7Mizoguehi A, Bhan AK. A ease for regulatory B cells [J]. lm- munol, 2006, 176(2):705-710.
  • 8Vitale G1, Mion F, Pueillo C.Regulatory B cells:evidence,deve- lopmental origin and population diversity [J]. Mol Immunol, 2010, 48(1-3):1-8.
  • 9Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote dis- ease progression[ J] . Clin Invest,2008,118( 10): 3420-3430.
  • 10Sicotte NL, Liva SM, Klutch R, et ol. Treatment of multiple sclerosis with the pregnancy hormone estriol [J]. Ann Neurol, 2002, 52(4): 421-428.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部